Methods for treating pancreatic cancer
Discloses the use of an anti-human progastrin (hPG) antibody for the manufacture of a medicament for use in the treatment of pancreatic cancer, wherein the antibody specifically binds to human progastrin polypeptide having an amino acid sequence of SEQ ID NO: 101, but does not bind to an amidated ga...
Gespeichert in:
Hauptverfasser: | , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!